| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb88e11c4ea1f8df837dd6932741e72d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L27-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194 |
| filingDate |
2021-05-25^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbc5ff5a59ec64485c1d8e9d6546969f |
| publicationDate |
2021-12-09^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021247289-A1 |
| titleOfInvention |
Reducing triglyceride levels and cortisol levels with pharmaceutical preparations |
| abstract |
The invention relates generally to the field of medical treatment. More particularly, the invention relates to treating a subject in order to reduce levels of triglycerides or cortisol by the administration of pharmaceutical formulations. |
| priorityDate |
2020-06-02^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |